Maintenance therapy is the last phase of treatment for acute lymphoblastic leukemia in children and adolescents. Although maintenance therapy is associated with toxicities and specific management issues, it is an essential phase of treatment that reduces the risk of relapse. The objective of this work is to propose a guide for the initiation, administration, and monitoring of maintenance therapy, and for the management of food, schooling, leisure, community life, risk of infection and links with family medicine.
Keywords: Acute lymphoblastic leukemia; Chimiothérapie; Hematology; Hématologie pédiatrique; Leucémie aiguë lymphoblastique; Maintenance therapy; Pediatrics; Pédiatrie; Recommandations; Traitement d’entretien.
Copyright © 2022 Société Française du Cancer. Published by Elsevier Masson SAS. All rights reserved.